Disc Medicine reviews ASH 2024 clinical data for bitopertin, DISC-0974, DISC-3405

Disc Medicine, Inc.

Company held conference call on Dec 8 to review data presented at ASH Annual Meeting.
Operational plans discussed alongside clinical updates for three pipeline programs.
Specific data results or guidance not provided in the 8-K filing; only presentation referenced.
Programs include bitopertin, DISC-0974, and DISC-3405.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.